000 03779nlm1a2200505 4500
001 668225
005 20231030042141.0
035 _a(RuTPU)RU\TPU\network\39449
035 _aRU\TPU\network\33755
090 _a668225
100 _a20220701a2022 k y0engy50 ba
101 0 _aeng
135 _adrcn ---uucaa
181 0 _ai
182 0 _ab
200 1 _aInfluence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment-free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design
_fL. M. Geers, T. Ochi, N. M. Vyalova [et al.]
203 _aText
_celectronic
300 _aTitle screen
330 _aBackground: Many antidepressants are substrates of P-glycoprotein, an efflux transporter in the blood-brain-barrier encoded by the ABCB1 gene. Genetic variations might influence the transport rate of antidepressants and hence their pharmacological effects. This study investigates the influence of eight polymorphisms in the ABCB1 gene on antidepressant treatment response. Method: 152 patients were included from psychiatric departments of the Mental Health Research Institute in Tomsk. The difference in Hamilton-Depression-Rating-Scale (HAMD-17)-scores between baseline and week two, week two and four, and baseline and week four was used to estimate timing of improvement of depression. Associations between the ABCB1 gene-polymorphisms and reduction in HAMD-17 score were assessed using independent t-test and multiple linear regression. Results: Tricyclic antidepressants were associated with a higher reduction of HAMD-17 score when compared to SSRIs. The SNP rs2235040 A-allele had a significant positive influence on the ΔHAMD-17(0→2W) score but a significant negative influence on the ΔHAMD-17(2→4W) score. The rs4148739 G-allele had a significant negative influence on the ΔHAMD-17(0→2W) score but a significant positive influence on the ΔHAMD-17(2→4W) score. The SNP rs2235015 T-allele is significant negatively related to the ΔHAMD-17(2→4W) score. Conclusion: ABCB1 Genetic variations appear to affect speed but not magnitude of antidepressant drug response.
461 _tHuman Psychopharmacology: Clinical and Experimental
463 _tVol. 37, iss. 3
_v[e2826, 10 p.]
_d2022
610 1 _aэлектронный ресурс
610 1 _aтруды учёных ТПУ
610 1 _aABCB1 gene
610 1 _aantidepressants
610 1 _aHamilton Depression Rating Scale
610 1 _aP-glycoprotein
610 1 _aгены
610 1 _aантидепрессанты
701 1 _aGeers
_bL. M.
_gLisanne
701 1 _aOchi
_bT.
_gTaichi
701 1 _aVyalova
_bN. M.
_gNataljya Mikhaylovna
701 1 _aLosenkov
_bI. S.
_cInnokenty Sergeevich
701 1 _aPaderina
_bD. Z.
_gDiana
701 1 _aPozhidaev
_bI. V.
_gIvan Vyacheslavovich
701 1 _aSimutkin
_bG. G.
_gGerman Gennadjevich
701 1 _aBokhan
_bN. A.
_gNikolay Aleksandrovich
701 1 _aWilffert
_bB.
_gBob
701 1 _aTouw
_bD. J.
_gDaniël
701 1 _aLoonen
_bA.
_gAnton
701 1 _aIvanova
_bS. A.
_cspecialist in the field of ecology and life safety
_cProfessor of Tomsk Polytechnic University, doctor of medical sciences
_f1964-
_gSvetlana Aleksandrovna
_2stltpush
_3(RuTPU)RU\TPU\pers\33859
712 0 2 _aНациональный исследовательский Томский политехнический университет
_bИнженерная школа неразрушающего контроля и безопасности
_bОтделение контроля и диагностики
_h7978
_2stltpush
_3(RuTPU)RU\TPU\col\23584
801 2 _aRU
_b63413507
_c20220701
_gRCR
856 4 _uhttps://doi.org/10.1002/hup.2826
942 _cCF